Novel Drug and Nutraceutical Delivery System for the Treatment of Inflammatory Bowel Disease †
Abstract
:Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Murtagh, A.; Higginbotham, C.; Heavey, P. Novel Drug and Nutraceutical Delivery System for the Treatment of Inflammatory Bowel Disease. Proceedings 2023, 91, 163. https://doi.org/10.3390/proceedings2023091163
Murtagh A, Higginbotham C, Heavey P. Novel Drug and Nutraceutical Delivery System for the Treatment of Inflammatory Bowel Disease. Proceedings. 2023; 91(1):163. https://doi.org/10.3390/proceedings2023091163
Chicago/Turabian StyleMurtagh, Aoife, Clement Higginbotham, and Patricia Heavey. 2023. "Novel Drug and Nutraceutical Delivery System for the Treatment of Inflammatory Bowel Disease" Proceedings 91, no. 1: 163. https://doi.org/10.3390/proceedings2023091163